FDA is committed to encouraging innovation and competition for biologics and facilitating the development of safe and effective biosimilars.
Similar Posts
Libby Laboratories, Inc. – 708259 – 06/27/2025
CGMP/Finished Pharmaceuticals/AdulteratedFDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA – 09/04/2024
FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDAYoCrunch® Products Voluntarily Recalled by Danone U.S. Due to Potential Presence of Plastic Pieces in Dome Topper
Danone U.S. is voluntarily recalling YoCrunch® products sold at retail stores nationwide due to the potential presence of plastic pieces in the dome topper. If consumed, the plastic pieces could potentially cause a choking response. The issue is isolated only to the separately packaged topper and doHerbsForever LLC Issues Allergy Alert on Undeclared Wheat in HerbsForever brand Dietary Supplements
01/07/2026 – HerbsForever LLC of Los Angeles, California is recalling 45 units of the product “Hingwastik Churna” and 45 units of “Gastro Care” dietary supplements because they may contain undeclared wheat. People who have a wheat allergy run a risk of serious or life-threatening allergic reactionsLEESAR, Inc. Fort Myers, FL. 483 issued 05/09/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 05/09/2025
Short Title (70 char) LEESAR, Inc. Fort Myers, FL. 483 issued 05/09/2025
FEI Number 3010166880
Firm Name LEESAR, Inc.
Record Type 483
State FL
Establishment Type Outsourcing FacilityMore Spotlight on CDER Science Articles
FDA scientists carry out laboratory, clinical and analytical research to address knowledge gaps in drug development, healthcare technologies and post-market drug monitoring. Spotlight on CDER Science features noteworthy scientific and research-oriented activities conducted within CDER.